Mayo Clinic home page [logo]

Search

Sub Navigation

The Campaign for Mayo Clinic

Discover how you can help support Mayo Clinic.

  • Print
  • Adjust type size:
  • Font size down
  • Font size up

Elliott Richelson, M.D.

Florida

Medical School

Johns Hopkins University School of Medicine, Baltimore, MD

Internship

Barnes Hospital and Washington University, St. Louis, MO

Residency

Johns Hopkins University School of Medicine, Baltimore, MD

Fellowship

Johns Hopkins University School of Medicine, Baltimore, MD

Certification

American Board of Psychiatry and Neurology

Academic Rank

Professor of Pharmacology and Psychiatry

Interests

Development of new-generation drugs for treatment of various neuropsychiatric disorders (one group of compounds that block transporters for serotonin, norepinephrine, and dopamine ["triple re-uptake inhibitors,"] may have antidepressant effects. Another class of compounds that are analogs of the active fragment of the endogenous neuropeptide neurotensin is being developed for treatment of schizophrenia, Parkinson's disease, and both somatic and neuropathic pain.), Studies on the mechanism of action of mood stabilizers, such as lithium salts.

Publications

See a listing of publications on PubMed, a service of the National Library of medicine.

Research

See a description of research activities.

Medical Services

Medical Services

Learn about treatment of diseases and becoming a patient. Read more about medical services.

Terms of Use and Information Applicable to this Site
Copyright ©2001-2008 Mayo Foundation for Medical Education and Research. All Rights Reserved.

.